PTC Therapeutics, Inc. (PTCT)

PTC Therapeutics Stock Forecast

Stock Price Forecast

The 13 analysts with 12-month price forecasts for PTC Therapeutics stock have an average target of 61.77, with a low estimate of 32 and a high estimate of 113. The average target predicts an increase of 17.46% from the current stock price of 52.59.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$32	$61.77	$63	$113
Change	-39.15%	+17.46%	+19.79%	+114.87%

Analyst Ratings

The average analyst rating for PTC Therapeutics stock from 13 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	2	2	2	2	2	2
Buy	3	4	5	5	6	6
Hold	4	4	3	3	2	2
Sell	1	1	1	1	1	1
Strong Sell	3	2	2	2	2	2
Total	13	13	13	13	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Louise Chen Scotiabank	Scotiabank	Hold Initiates $55	Hold	Initiates	$55	+4.58%	Mar 7, 2025
Jeffrey Hung Morgan Stanley	Morgan Stanley	Buy Initiates $67 → $70	Buy	Initiates	$67 → $70	+33.11%	Mar 7, 2025
Eric Joseph JP Morgan	JP Morgan	Buy Maintains $74 → $72	Buy	Maintains	$74 → $72	+36.91%	Feb 28, 2025
Brian Abrahams RBC Capital	RBC Capital	Buy Maintains $60 → $63	Buy	Maintains	$60 → $63	+19.79%	Feb 18, 2025
David Lebowitz Citigroup	Citigroup	Strong Sell Maintains $32 → $45	Strong Sell	Maintains	$32 → $45	-14.43%	Feb 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

859.50M

Increased by 6.53%

from 806.78M

Revenue Next Year

892.39M

Increased by 3.83%

from 859.50M

EPS This Year

-0.71

from -4.73

EPS Next Year

-1.98

from -0.71

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	380.77M	538.59M	698.80M	937.82M	806.78M	859.50M	892.39M	1.13B
Revenue Growth	24.04%	41.45%	29.75%	34.20%	-13.97%	6.53%	3.83%	26.74%
EPS	-6.64	-7.43	-7.79	-8.37	-4.73	-0.71	-1.98	1.95
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	26.99
No. Analysts	-	-	-	-	-	17	16	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	2.3B	1.2B	1.5B
Avg	859.5M	892.4M	1.1B
Low	642.5M	681.1M	854.6M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	178.9%	37.6%	69.7%
Avg	6.5%	3.8%	26.7%
Low	-20.4%	-20.8%	-4.2%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	12.60	1.37	3.55
Avg	-0.71	-1.98	1.95
Low	-7.39	-7.22	0.43

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.